CSL inaugurates new R&D center in Germany

Drugs

The global biotech’s M600 R&D center is situated on the grounds of the research campus in Marburg’s Görzhausen Industrial Park. Construction began in November 2019 and will be completed later this calendar year.

The R&D campus is nearly 40,000 sqm in size and includes 7,000 sqm of laboratory space, 7,000 sqm of workspace, and 800 sqm of space for start-ups from the region. It will also provide space for around 500 CSL research and development employees as well as academic and cooperation partners.

Sustainability was at the ‘forefront of the design’ of the new building. Construction was planned in accordance with the KfW (German government investment and development bank) eligibility criteria for green financing. 

The investment is in line with the UN Sustainable Development Goals. It contributes to the Sustainable Development Goals No. 7 (affordable and clean energy) and No. 13 (climate protection). Special features of the modern energy concept include equipping the building with an ice storage system and heat pumps.

M600 is equipped with advanced laboratories and technical resources and combines various forms of working areas for active work under one roof.

In addition, the building also houses laboratory space for external collaborators, with the aim of contributing to the overall R&D ecosystem (it is located near universities, institutes and biomedical centers, with the advantage of providing ‘efficient access to external talent’).

“Investing in Marburg makes sense for us as this region helped shape CSL today,”​ said Paul Perreault, CSL CEO and Managing Director. “The building complex was constructed using state-of-the-art technologies in accordance with strict sustainability criteria and will make Marburg, Central Hesse, and Hesse a beacon of biotechnology far beyond the state and national borders.”

Products You May Like

Leave a Reply

Your email address will not be published. Required fields are marked *